IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Effector Therapeutics Inc

CUSIP: 28202V958 | 3 institutional holders

Quarters

Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q4 2023

Sabby Management, LLC100,000
0.0% of portfolio›$46.7K
StyleTurnoverLocationFiled
Sabby Management, LLC
100,000$46.7K0.0%GrowthVery HighMiami Beach, FL2024-02-14